SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 129 filers reported holding SCICLONE PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $606,000 | -35.2% | 55,104 | -42.3% | 0.24% | -21.5% |
| Q1 2017 | $935,000 | -40.1% | 95,432 | -34.0% | 0.30% | -27.3% |
| Q4 2016 | $1,561,000 | +22.2% | 144,575 | +16.0% | 0.42% | +36.3% |
| Q3 2016 | $1,277,000 | +138.2% | 124,590 | +203.7% | 0.31% | +209.1% |
| Q2 2016 | $536,000 | +23.5% | 41,018 | +4.0% | 0.10% | +57.1% |
| Q1 2016 | $434,000 | -80.3% | 39,438 | -83.5% | 0.06% | -73.4% |
| Q4 2015 | $2,200,000 | -2.0% | 239,104 | -26.1% | 0.24% | +9.7% |
| Q3 2015 | $2,245,000 | -4.4% | 323,415 | +35.3% | 0.22% | -5.7% |
| Q2 2015 | $2,348,000 | +126.4% | 239,072 | +104.2% | 0.23% | +124.5% |
| Q1 2015 | $1,037,000 | -14.1% | 117,059 | -15.1% | 0.10% | -11.3% |
| Q4 2014 | $1,207,000 | -16.1% | 137,815 | -34.0% | 0.12% | -8.0% |
| Q3 2014 | $1,439,000 | +578.8% | 208,800 | +395.3% | 0.12% | +1150.0% |
| Q4 2013 | $212,000 | -83.0% | 42,157 | -82.8% | 0.01% | -82.5% |
| Q3 2013 | $1,246,000 | -56.0% | 245,681 | -56.9% | 0.06% | -52.1% |
| Q2 2013 | $2,830,000 | – | 570,502 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,663,281 | $16,300,000 | 9.19% |
| Nantahala Capital Management | 1,891,328 | $18,535,000 | 2.06% |
| Nine Chapters Capital Management LLC | 40,700 | $399,000 | 0.54% |
| MENTA CAPITAL LLC | 396,336 | $3,884,000 | 0.38% |
| Sapphire Star Partners LP | 30,439 | $298,000 | 0.34% |
| TFS CAPITAL LLC | 95,432 | $935,000 | 0.30% |
| Ativo Capital Management LLC | 123,428 | $1,210,000 | 0.30% |
| GLG Partners LP | 363,188 | $3,559,000 | 0.17% |
| GSA CAPITAL PARTNERS LLP | 240,013 | $2,352,000 | 0.13% |
| Bowling Portfolio Management LLC | 68,473 | $671,000 | 0.11% |